This notice was published on December 7, 2022.
Minoxidil replaces Loniten.
Do you disagree with any other decision rendered by RAMQ? You have 6 months to contest the decision by filing an application for review.
Form 4185
This notice was published on October 20, 2020.
Timolol maleate replaces:
This notice was published on April 24, 2025.
Ropeginterferon alfa-2B (Besmeri) replaces Pegasys.
This notice was published on April 24, 2024.
Lidocaine hydrochloride replaces Lidocaine hydrochloride.
Form used to confirm the place of residence of a person or family. Must be signed before a commissioner for oaths. The form remains valid for 45 days.
Form 4249
RAMQ publishes information and documents in keeping with the Regulation respecting the distribution of information and the protection of personal information.
RAMQ applies rigorous security and privacy measures on its website in order to safeguard users’ personal information and privacy.
